Back to top

Morgan Stanley Sticks to Its Buy Rating for Novonesis (0Q4U)

Morgan Stanley analyst Thomas Wrigglesworth maintained a Buy rating on Novonesis today and set a price target of DKK552.00. According to TipRanks, ...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Novozymes A/S (NVZMY)